422 related articles for article (PubMed ID: 18332071)
1. Comparison of tissue plasminogen activator-antibiotic locks with heparin-antibiotic locks in children with catheter-related bacteraemia.
Onder AM; Chandar J; Simon N; Diaz R; Nwobi O; Abitbol CL; Zilleruelo G
Nephrol Dial Transplant; 2008 Aug; 23(8):2604-10. PubMed ID: 18332071
[TBL] [Abstract][Full Text] [Related]
2. PREFABL: predictors of failure of antibiotic locks for the treatment of catheter-related bacteraemia.
Onder AM; Billings A; Chandar J; Francoeur D; Simon N; Abitbol C; Zilleruelo G
Nephrol Dial Transplant; 2010 Nov; 25(11):3686-93. PubMed ID: 20501464
[TBL] [Abstract][Full Text] [Related]
3. Treatment of catheter-related bacteremia with tissue plasminogen activator antibiotic locks.
Onder AM; Chandar J; Simon N; Saint-Vil M; Francoeur D; Nwobi O; Abitbol C; Zilleruelo G
Pediatr Nephrol; 2008 Mar; 23(3):457-64. PubMed ID: 18064496
[TBL] [Abstract][Full Text] [Related]
4. Prevention of catheter-related bacteremia in pediatric intestinal transplantation/short gut syndrome children with long-term central venous catheters.
Onder AM; Kato T; Simon N; Rivera-Hernandez M; Chandar J; Montane B; Francoeur D; Salvaggi G; Tzakis AG; Zilleruelo G
Pediatr Transplant; 2007 Feb; 11(1):87-93. PubMed ID: 17239129
[TBL] [Abstract][Full Text] [Related]
5. Antibiotic-lock therapy for long-term intravascular catheter-related bacteraemia: results of an open, non-comparative study.
Fernandez-Hidalgo N; Almirante B; Calleja R; Ruiz I; Planes AM; Rodriguez D; Pigrau C; Pahissa A
J Antimicrob Chemother; 2006 Jun; 57(6):1172-80. PubMed ID: 16597634
[TBL] [Abstract][Full Text] [Related]
6. Antibiotic lock solutions for the prevention of catheter-related bacteraemia in haemodialysis patients.
Chow KM; Poon YL; Lam MP; Poon KL; Szeto CC; Li PK
Hong Kong Med J; 2010 Aug; 16(4):269-74. PubMed ID: 20683069
[TBL] [Abstract][Full Text] [Related]
7. Treatment of long-term intravascular catheter-related bacteraemia with antibiotic-lock therapy.
Fortún J; Grill F; Martín-Dávila P; Blázquez J; Tato M; Sánchez-Corral J; García-San Miguel L; Moreno S
J Antimicrob Chemother; 2006 Oct; 58(4):816-21. PubMed ID: 16899468
[TBL] [Abstract][Full Text] [Related]
8. A randomized trial comparing gentamicin/citrate and heparin locks for central venous catheters in maintenance hemodialysis patients.
Moran J; Sun S; Khababa I; Pedan A; Doss S; Schiller B
Am J Kidney Dis; 2012 Jan; 59(1):102-7. PubMed ID: 22088576
[TBL] [Abstract][Full Text] [Related]
9. Prophylaxis of catheter-related bacteremia using tissue plasminogen activator-tobramycin locks.
Onder AM; Chandar J; Billings A; Simon N; Gonzalez J; Francoeur D; Abitbol C; Zilleruelo G
Pediatr Nephrol; 2009 Nov; 24(11):2233-43. PubMed ID: 19590902
[TBL] [Abstract][Full Text] [Related]
10. Catheter-related bacteraemia in haemodialysis patients with HIV infection.
Mitchell D; Krishnasami Z; Allon M
Nephrol Dial Transplant; 2006 Nov; 21(11):3185-8. PubMed ID: 16891646
[TBL] [Abstract][Full Text] [Related]
11. Infection associated with tunneled hemodialysis catheters.
Beathard GA; Urbanes A
Semin Dial; 2008; 21(6):528-38. PubMed ID: 19000122
[TBL] [Abstract][Full Text] [Related]
12. A vancomycin-heparin lock solution for prevention of nosocomial bloodstream infection in critically ill neonates with peripherally inserted central venous catheters: a prospective, randomized trial.
Garland JS; Alex CP; Henrickson KJ; McAuliffe TL; Maki DG
Pediatrics; 2005 Aug; 116(2):e198-205. PubMed ID: 15995005
[TBL] [Abstract][Full Text] [Related]
13. Catheter locks, heparin and biofilm: what is this the risk?
Diskin CJ; Stokes TJ; Dansby L; Radcliff L; Carter TB
Nephrol Dial Transplant; 2008 Aug; 23(8):2708-9. PubMed ID: 18544629
[No Abstract] [Full Text] [Related]
14. Biofilm formation in long-term central venous catheters in children with cancer: a randomized controlled open-labelled trial of taurolidine versus heparin.
Handrup MM; Fuursted K; Funch P; Møller JK; Schrøder H
APMIS; 2012 Oct; 120(10):794-801. PubMed ID: 22958287
[TBL] [Abstract][Full Text] [Related]
15. Comparison of low-dose gentamicin with minocycline as catheter lock solutions in the prevention of catheter-related bacteremia.
Nori US; Manoharan A; Yee J; Besarab A
Am J Kidney Dis; 2006 Oct; 48(4):596-605. PubMed ID: 16997056
[TBL] [Abstract][Full Text] [Related]
16. Preventing haemodialysis catheter-related bacteraemia with an antimicrobial lock solution: a meta-analysis of prospective randomized trials.
Labriola L; Crott R; Jadoul M
Nephrol Dial Transplant; 2008 May; 23(5):1666-72. PubMed ID: 18065789
[TBL] [Abstract][Full Text] [Related]
17. Predictors and outcome of catheter-related bacteremia in children on chronic hemodialysis.
Onder AM; Chandar J; Coakley S; Abitbol C; Montane B; Zilleruelo G
Pediatr Nephrol; 2006 Oct; 21(10):1452-8. PubMed ID: 16897007
[TBL] [Abstract][Full Text] [Related]
18. Preventing catheter-related infections in children undergoing hemodialysis.
Stefanidis CJ
Expert Rev Anti Infect Ther; 2010 Nov; 8(11):1239-49. PubMed ID: 21073289
[TBL] [Abstract][Full Text] [Related]
19. Analysis of risk factors for catheter-related bacteremia in 2000 permanent dual catheters for hemodialysis.
Lemaire X; Morena M; Leray-Moragués H; Henriet-Viprey D; Chenine L; Defez-Fougeron C; Canaud B
Blood Purif; 2009; 28(1):21-8. PubMed ID: 19325236
[TBL] [Abstract][Full Text] [Related]
20. Antibiotic lock solutions allow less systemic antibiotic exposure and less catheter malfunction without adversely affecting antimicrobial resistance patterns.
Onder AM; Billings AA; Chandar J; Nield L; Francoeur D; Simon N; Abitbol C; Zilleruelo G
Hemodial Int; 2013 Jan; 17(1):75-85. PubMed ID: 22716190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
